Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04790695 | Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab | completed | Phase 2 | 1 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT03602885 | EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | completed | N/A | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT04191928 | Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy(PAP-UP) | completed | Phase 1 | 4 | Thomas Jefferson UniversityOTHER | 1 | Dec 23, 2021 | clinicaltrials |
| NCT02125136 | Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer(NEOLAP) | completed | Phase 2 | 168 | AIO-Studien-gGmbHOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT02259725 | Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors | completed | Phase 2 | 3 | University of Southern CaliforniaOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT05025371 | The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma | completed | — | 312 | Iuliu Hatieganu University of Medicine and PharmacyOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT02648880 | Preoperative Exercise in Pancreatic Cancer | completed | N/A | 3 | University of Colorado, DenverOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT01357525 | SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma | completed | N/A | 50 | David A. Clump, MD, PhDOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT02787187 | Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? | completed | N/A | 230 | Ruijin HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT03319459 | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors | completed | Phase 1 | 44 | Fate TherapeuticsINDUSTRY | 1 | Nov 22, 2021 | clinicaltrials |
| NCT03187028 | Diet and Exercise After Pancreatic Cancer(PACE) | completed | N/A | 15 | University of Alabama at BirminghamOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT03645148 | Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 7 | Zhejiang Provincial People's HospitalOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04937322 | Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. | completed | — | 8 | Methodist Health SystemOTHER | 1 | Nov 11, 2021 | clinicaltrials |
| NCT01303172 | A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Immodulon Therapeutics LtdINDUSTRY | 5 | Nov 10, 2021 | clinicaltrials |
| NCT01660711 | A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma | completed | Phase 2 | 22 | Endeavor HealthOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT05110573 | Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy(PSMLOPD) | completed | — | 172 | General Hospital GroeningeOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03410914 | Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy(PATCH-DP) | completed | Phase 2 | 52 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 3, 2021 | clinicaltrials |
| NCT03023722 | Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer | completed | Phase 2 | 18 | Yale UniversityOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT04846985 | Nutritional Problems in Pallative Cancer | completed | — | 44 | Jens Rikardt AndersenOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT02591082 | Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter | completed | — | 25 | RenovoRxINDUSTRY | 1 | Oct 20, 2021 | clinicaltrials |
| NCT04716166 | Incentive Spirometry and Upper Abdominal Laparoscopic Surgery | completed | N/A | 60 | Riphah International UniversityOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT01523808 | Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer | completed | Phase 1 | 12 | ERYtech PharmaINDUSTRY | 0 | Oct 15, 2021 | clinicaltrials |
| NCT02245217 | Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients | completed | N/A | 9 | University of UtahOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03632850 | Web-based Treatment Information Tool for People With Advanced Pancreatic Cancer | completed | — | 34 | Bournemouth UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03644173 | Personal Resilience Empowerment Program Study | completed | N/A | 37 | Hackensack Meridian HealthOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT02282722 | Improving Informed Consent for Palliative Chemotherapy | completed | N/A | 216 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT02308722 | SBRT Pre-operatively for Pancreatic Cancer(SPARC) | completed | Phase 1 | 12 | University of OxfordOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT03738787 | Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy | completed | Phase 2 | 40 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04528745 | The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients | completed | — | 52 | University of CopenhagenOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT03446872 | Post Marketing Surveillance Study for ONIVYDE® in South Korea | completed | — | 94 | Institut de Recherches Internationales ServierOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT00112580 | MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 27 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 27, 2021 | clinicaltrials |
| NCT03261947 | A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors | completed | Phase 2 | 101 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Sep 20, 2021 | clinicaltrials |
| NCT00010166 | Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 2 | 26 | Wake Forest University Health SciencesOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT00025168 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 2 | 20 | Wake Forest University Health SciencesOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT02343835 | Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer | completed | N/A | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02777710 | Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers(MEDIPLEX) | completed | Phase 1 | 48 | Centre Leon BerardOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04310111 | EUS-RFA for Unresectable Pancreatic Cancer | completed | N/A | 8 | First People's Hospital of HangzhouOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT00041639 | Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 75 | Gilead SciencesINDUSTRY | 4 | Aug 19, 2021 | clinicaltrials |
| NCT00597129 | Safety and Efficacy Study of 90Y-hPAM4 at Different Doses | completed | Phase 1 / Phase 2 | 21 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT05012540 | SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)(SII) | completed | — | 214 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Aug 19, 2021 | clinicaltrials |
| NCT02138383 | Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer | completed | Phase 1 | 25 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT02250638 | Longitudinal Pancreatic Cancer Study | completed | — | 140 | Fujirebio Diagnostics, Inc.INDUSTRY | 2 | Aug 17, 2021 | clinicaltrials |
| NCT00603863 | Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 80 | Gilead SciencesINDUSTRY | 1 | Aug 16, 2021 | clinicaltrials |
| NCT04293497 | Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer | completed | N/A | 97 | Gangnam Severance HospitalOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | completed | Phase 1 / Phase 2 | 141 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 11, 2021 | clinicaltrials |
| NCT01666730 | Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT02812992 | Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients(GrantPax) | completed | Phase 4 | 32 | AIO-Studien-gGmbHOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT01465659 | Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 29 | Northwestern UniversityOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT03316599 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 26 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 3, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Jan 12, 2022source: clinicaltrials